Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

NCT05013112 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation
Metabolic Disorder
Metformin
Empagliflozin

Interventions

DRUG: SGLT2 inhibitor
DRUG: Metformin
OTHER: Placebo

Sponsor

West China Hospital